RA Capital Management’s Instil Bio TIL Stock Holding History

RA Capital Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-383,540	Closed	-$37.1M	–	83
2022 Q3	$37.1M	Hold	383,540	–	–	0.79%	38
2022 Q2	$35.4M	Buy	383,540 +140,000	+57%	+$19.8M	0.94%	33
2022 Q1	$52.4M	Hold	243,540	–	–	1.14%	28
2021 Q4	$83.3M	Hold	243,540	–	–	1.47%	19
2021 Q3	$87.1M	Hold	243,540	–	–	1.21%	26
2021 Q2	$94.1M	Hold	243,540	–	–	1.51%	17
2021 Q1	$122M	Buy	+243,540	New	+$125M	1.84%	13

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RA Capital Management's TIL Position: Q4 2022 in Review

RA Capital Management sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 383,540 shares — an estimated $37.1M sold.

RA Capital Management first reported a position in TIL in Q1 2021 and held it in 7 quarters. The position peaked at $122M in Q1 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

RA Capital Management reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
RA Capital Management sold 383,540 Instil Bio shares in Q4 2022, an estimated $37.1M.
RA Capital Management first reported a position in Instil Bio in Q1 2021 and held it in 7 quarters.
RA Capital Management's Instil Bio position peaked at $122M in Q1 2021.
78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.